Newsfeeds Archive - Spark Newswire

3 minute read

KORE Announces President And CEO Transition; Romil Bahl To Step Down And Ronald Totton Named As Interim President And CEO, Effective May 3, 2024

April 29, 10:01 AM

Romil Bahl to step down and Ronald Totton named as Interim President and CEOATLANTA, April 29, 2024 /PRNewswire/ -- KORE Group Holdings, Inc. (NYSE:KORE) ("KORE," the "Company," "we" or "our"), a global leader in

KORE

1 minute read

Earnings

Earnings Scheduled For April 11, 2024

By Benzinga Insights

April 11, 6:14 AM

Companies Reporting Before The Bell • Kore Group Holdings (NYSE:KORE) is estimated to report quarterly loss at $0.05 per share on revenue of $77.79 million.

AGX

1 minute read

Movers

12 Communication Services Stocks Moving In Wednesday’s Pre-Market Session

By Benzinga Insights

April 10, 8:09 AM

Gainers Kore Group Holdings (NYSE:KORE) shares increased by 13.9% to $0.78 during Wednesday’s pre-market session. The market value…

AEHL

3 minute read

Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Avi Kapoor

January 9, 2:00 PM

Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session.

ACCD

4 minute read

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Avi Kapoor

January 5, 2:13 PM

Shares of Applied Therapeutics, Inc.

AGL

3 minute read

Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket

By Avi Kapoor

January 5, 9:03 AM

Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis. Dermata Therapeutics shares jumped 57.3% to $0.9601 in pre-market trading.

AIMD

4 minute read

Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Avi Kapoor

January 2, 2:35 PM

Shares of Longboard Pharmaceuticals, Inc.

ADTX

2 minute read

Why LumiraDx Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket

By Avi Kapoor

January 2, 9:07 AM

Shares of LumiraDx Limited (NASDAQ: LMDX) fell sharply in pre-market trading after the company agreed to sell its point-of-care technology platform to Roche. LumiraDx shares dipped 19.7% to $0.0517 in pre-market trading. Here are some other stocks moving in pre-market trading.

ADTX